Eyewear Market Size Worth $ 278.95 Billion By 2028: Grand View Research Inc.

San Francisco, 29 Jan 2021: The Report Eyewear Market Size, Share & Trends Analysis Report By Product (Contact Lenses, Spectacles, Sunglasses), By Distribution Channel, By Region, And Segment Forecasts, 2021 – 2028

The global eyewear market size is anticipated to reach USD 278.95 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to exhibit a CAGR of 8.5% during the forecast period. Advancements in lens-making technology enable eyewear manufacturers to produce large quantities of eye lenses, thus providing users with more affordable and diverse buying options. The integration of 3D printing technology with the eyewear manufacturing process further offers eyewear providers the opportunity to exercise efficient resource management and mitigate costs associated with extensive inventories, limited product design, and complicated supply chains.

The rising demand for customized eyewear among users is fueling the market growth. People prefer unique products that are tailored according to their needs, such as the shape of eyes and face, color and texture of glasses, and the frame’s design and material. This is expected to result in the disruption of distribution models to meet end-users’ demands, thus offering market growth opportunities over the next few years. To cater to this trend, an increasing number of eyewear manufacturers, such as Topology and Pair Eyewear, have started offering customized eyewear to their customers. These customized eyewear products include glasses with different features, such as eliminating UV radiation, photochromic glasses, and glasses with a high index number.

The amalgamation of digital channels with the eyewear value chain in recent years has increased the sales of eyewear products significantly. The e-commerce distribution channel is gradually gaining momentum due to the ongoing COVID-19 pandemic, which encourages users to practice social distancing and order from their homes. Several eyewear companies, including Lenskart, are offering users the opportunity to make calculated spectacle buying decisions by providing virtual facial analysis and product virtualization facilities. Additionally, establishing digital channels allows companies to maintain essential customer data such as their buying preferences, search history, and feedback, which can help them offer more curated and specific products to their customers in the future.

The emerging demand to practice sustainability among eyewear companies and their customers is changing the market dynamics. Eyewear manufacturers such as Evergreen Eyecare and Modo have started using eco-friendly materials in eyewear designs, which helps the company practice sustainable development and enhance its customer journey. The trend is encouraging newer eyewear manufacturers such as Shwood Eyewear and PaperStyle to diversify their products and offer more ecological, budget-friendly, and unique products to customers while also capture a better revenue share. Companies are experimenting with materials such as wood, paper, leather, and wool to design eyewear with innovative textures, which promises to attract more customers.

Access Research Report of Eyewear Market @ https://www.grandviewresearch.com/industry-analysis/eyewear-industry

Eyewear Market Report Highlights

• In terms of product, the sunglasses segment is expected to emerge as the fastest-growing segment over the forecast period. The promising growth prospects of the segment can be attributed to the gradual easing of travel restrictions, which is promoting people to use sunglasses as a travel accessory.
• In terms of the distribution channel, the e-commerce segment is envisioned to register the highest growth rate over the forecast period. This can be attributed to the better functionality, ease of access, better discounts, and better buying options offered by online players.
• The Asia Pacific region is expected to register the highest CAGR over the forecast period. This can be chiefly attributed to the resumption of eyewear and eyewear parts manufacturing and essential supply chain activities in China, which is a major supplier of eyewear parts in the world.
• The growing demand for colored contact lenses and increasing penetration of soft contact lenses in Japan and China is further promoting the demand for eyewear in the Asia Pacific region.
• In response to the COVID-19 pandemic, companies rapidly deployed their IT capabilities to execute remote connections with employees and customers to deliver a productive and functional, and productive Work From Home (WFH) strategy, which has kept the market buoyant.

List of Key Players in the Eyewear Market

• Johnson & Johnson Vision Care, Inc.
• ESSILORLUXOTTICA
• CooperVision
• Carl Zeiss AG.
• Bausch & Lomb Inc.
• Safilo Group S.p.A.

Access Press Release of Eyewear Market @ https://www.grandviewresearch.com/press-release/global-eyewear-market

Product Design And Development Services Market Expanding At A CAGR Of 11.6%For The Forecast Period From 2021 To 2028: Grand View Research Inc.

San Francisco, 29 Jan 2021: The Report Product Design And Development Services Market Size, Share & Trends Analysis Report By Services, By Application (Diagnostic Equipment, Surgical Instruments), By End Use, By Region, And Segment Forecasts, 2021 – 2028

The global product design and development services market size is expected to reach USD 18.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. Low product cost, short time-to-market, and demand for advanced technologies are some of the factors boosting the growth. Medical and life sciences companies face extreme cost pressures to develop new and innovative products in shorter time frames while complying with stringent regulatory requirements of medical device.

The manufacturers face more hurdles in getting cost-effective high-quality products to market faster along with some internal factors, such as designing and production. Hence, medical device companies adopt a design-to-manufacturing approach where design, engineering, as well as production teams work in collaboration to develop the product model. This approach enhances both product quality and profitability by decreasing errors in development and designing thereby increasing success rates.

Outsourcing design engineering is anticipated to witness healthy growth over the forecast period as an increased number of manufacturers—from start-up ventures to established companies—capitalize on the benefits related to outsourcing design engineering such as improved product design and cost-effectiveness to attain a competitive edge. Furthermore, with the incorporation of IT into healthcare industry, analysis on 3D models and software, for which the third parties are well trained are expected to promote growth.

However, COVID-19 has added complexity and challenge to the medical device innovation. The product development firms are facing the major challenges so far as how to continue with business operations while evading the effects of the crisis. Product development during the pandemic continues to show optimal scope. The huge cost of development, financial risks of missing the mark, and market timing altogether contribute to the greatest challenges of medical device development and market driving innovation.

Access Research Report of Product Design And Development Services Market @ https://www.grandviewresearch.com/industry-analysis/product-design-development-services-market

Product Design & Development Services Market Report Highlights

• The research, strategy, and concept generation services segment accounted for the highest revenue share of 39.9% in 2020 as the stage requires extensive research and business and design strategy that generate maximum revenue
• The surgical instruments segment held major market share of 27.9% in 2020, due to the complexity of instruments which require detailed designing for making them suitable for direct contact with human body
• Key players in emerging economies of Asia Pacific and Latin America are witnessing significant increase in their revenue owing to the presence of lucrative growth opportunities
• Medical device Original Equipment Manufacturers (OEMs) are outsourcing the production of their devices to developing economies due to availability of labor and raw materials at affordable cost

List of Key Players of Product Design And Development Services Market

• Ximedica
• DeviceLab Inc.
• Jabil Inc.
• Flex Ltd.
• Plexus Corp.
• Celestica Inc.
• Starfish Medical
• Nordson Medical
• Planet Innovation
• Donatelle

Access Press Release of Product Design And Development Services Market @ https://www.grandviewresearch.com/press-release/global-product-design-development-services-market

Biopharmaceutical CMO And CRO Market Size Is Estimated To Reach USD 49.2 Billion By 2028: Grand View Research Inc.

San Francisco, 29 Jan 2021: The Report Biopharmaceutical CMO And CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service Type (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2021 – 2028

The global biopharmaceutical CMO and CRO market size is expected to reach USD 49.2 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.6% from 2021 to 2028. The market is significantly driven by the growing interest of conventional drug developers in biological therapeutics. At present, outsourcing has become a cost-saving strategy for small to medium-sized bio-manufacturers as it helps in eliminating the need for establishing costly specialized facilities or hiring and training personnel.

The global market for biopharmaceutical CMO and CRO is expected to thrive during the pandemic owing to positive pipeline development across modalities. For instance, Lonza and Moderna announced a ten-year collaboration for the commercial manufacturing of the COVID-19 vaccine. Such developments compensated for minor delays in clinical trials that occurred during the first half of 2020. The contract manufacturing organization segment is projected to unlock lucrative growth opportunities over the foreseeable future.

The decline in R&D productivity and increased development costs have resulted in high pressure on biopharmaceutical manufacturers pertaining to short-term earnings and profit margins. This, in turn, has created lucrative opportunities for the CMOs and CROs to accelerate their business operations.

The mammalian source segment dominated the market in 2020. CMOs are engaged in standardizing their mammalian systems, thereby driving the revenue growth in the mammalian segment. Plant-based expression systems are developed and explored as a cost-effective alternative for the production of large molecules.

The robustness of venture capital investments is one of the important supportive factors that has created opportunities for the growth of CMOs. Venture capital funds are considered more reliable than public equity. An increase in the availability of venture funds for life sciences is expected to bolster the growth of CMOs.

However, these CMOs and CROs are facing competition from in-house departments of pharmaceutical and biotechnology companies. Several big pharma companies like Novartis announced to keep their biomanufacturing process in-house.

Some key CMOs are Lonza; Boehringer Ingelheim GmbH; Patheon; Samsung BioLogics; and FUJIFILM Diosynth Biotechnologies U.S.A., Inc. The key players are involved in establishing mutually beneficial alliances with other emerging CMOs to scale up their production capabilities.

Access Research Report of Biopharmaceutical CMO And CRO Market @ https://www.grandviewresearch.com/industry-analysis/biopharmaceutical-cmo-cro-market

Biopharmaceutical CMO & CRO Market Report Highlights

• Based on source, mammalian cell line-based bioproduction system accounted for the largest revenue share of 54.0% in 2020 due to the growth in mammalian system titers and yields
• By service type, contract manufacturing services accounted for the largest share of 57.7% in 2020 owing to the presence of a wide range of services from cell line development to the final packaging of the product
• Contract research services are expected to expand at the fastest CAGR of 8.4% over the forecast period. This can be attributed to increasing investment in research programs for the development of novel therapeutics
• In terms of product, biologics held the largest share of 81.8% in 2020. In recent times, biologics manufacturing is becoming more specialized, as a result of which CMOs have become an integral part of the biologics production strategies of clients
• North America held the largest share of 33.8% in 2020. The North American biopharmaceutical research industry is recognized as a leader in biopharmaceutical innovations. Several biopharma companies from the U.S. are considering Asian countries for the development of pharma products. This is primarily due to the growing costs of R&D in their home country and the presence of low-cost production facilities and cheap labor in Asian countries

List of Key Players of the Biopharmaceutical CMO & CRO Market

• Boehringer Ingelheim GmbH
• Lonza
• Inno Biologics Sdn Bhd
• Rentschler Biotechnologie GmbH
• JRS PHARMA
• BIOMEVA GmbH
• ProBioGen
• FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
• TOYOBO CO., LTD.
• Samsung BioLogics

Access Press Release of Biopharmaceutical CMO And CRO Market @ https://www.grandviewresearch.com/press-release/global-biopharmaceutical-cmo-cro-market

Non Invasive Prenatal Testing Market Projected To Exhibit Robust CAGR of 10.9%For The Forecast Period From 2021 To 2028: Grand View Research Inc.

San Francisco, 29 Jan 2021: The Report Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Risk Type, By Method, By Technology, By Product, By End-use, And Segment Forecasts, 2021 – 2028

The global non invasive prenatal testing market size is anticipated to reach USD 6.5 billion by 2028 registering a CAGR of 10.9%, according to a new report by Grand View Research, Inc. High adoption and demand for early non-invasive prenatal testing (NIPT) coupled with improvements in reimbursement scenario are among the factors driving the market.

The use of invasive techniques of prenatal testing, such as chorionic villus sampling and amniocentesis, can lead to issues, such as miscarriage. This has led to a decline in the use of these procedures and high demand for tests that are more efficient, non-invasive, and safe. Furthermore, non-invasive fetal tests have a lower failure and false-positive rate, which has resulted in a considerable increase in uptake of non-invasive tests in the last few years.

The non-invasive prenatal testing market is highly saturated with the existing key players. Companies are forming partnerships and collaborations to maintain a stable position in the market. For instance, in August 2020, Eurofins Scientific announced an agreement with Noritsu Koki Co., Ltd. for the acquisition of GeneTech Inc., one of the pioneering NIPT developers in Japan. With this acquisition, Eurofins Scientific is set to strengthen its presence in the Japanese NIPT market.

Access Research Report of Non Invasive Prenatal Testing Market @ https://www.grandviewresearch.com/industry-analysis/noninvasive-prenatal-testing-market

Non-invasive Prenatal Testing Market Report Highlights

• The 13-24 weeks gestation period segment accounted for the largest revenue share in 2020 owing to the presence of a maximum number of tests carried out in this phase of pregnancy
• NIPT for high- & average-risk pregnancy led the market owing to the presence of favorable payer reimbursement policies in this segment
• Next-Generation Sequencing (NGS) is estimated to be the largest as well as the fastest-growing technology segment from 2021 to 2028, as NGS is the most commonly used method for NIPT
• The diagnostic laboratories end-use segment held the largest revenue share in 2020 and will expand further at the fastest CAGR from 2021 to 2028 due to the rising number of diagnostic laboratories across the globe that offer NIPT
• Asia Pacific is expected to register the fastest year-on-year growth owing to the gradually increasing average maternal age and rising incidence of chromosomal aneuploidies
• One of the key trends followed by market participants includes licensing of the test to other labs and generating significant revenue by collecting royalty payments

List of Key Players of Non-invasive Prenatal Testing Market

• Genesis Genetics (CooperSurgical, Inc.)
• Natera, Inc.
• Centogene N.V.
• Illumina, Inc. (Verinata Health, Inc.)
• Eurofins LifeCodexx GmbH
• MedGenome Labs Ltd.
• Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
• Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.)
• Progenity, Inc.
• Qiagen
• Laboratory Corp. of America Holdings
• Quest Diagnostics, Inc.

Access Press Release of Non Invasive Prenatal Testing Market @ https://www.grandviewresearch.com/press-release/global-noninvasive-prenatal-testing-market

3D Cell Culture Market Projected To Expand At A CAGR 10.7% For The Forecast Period From 2021 To 2028: Grand View Research Inc.

San Francisco, 29 Jan 2021: The Report 3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold-free, Scaffold-based), By Application (Cancer, Stem Cell Research), By End Use, By Region, And Segment Forecasts, 2021 – 2028

The global 3D cell culture market size is expected to reach USD 3.48 billion by 2028 registering a CAGR of 10.7%, according to a new report by Grand View Research, Inc. The development of 3D optimized assays, kits, and protocols coupled with the evolution of assay techniques is anticipated to drive the three-dimensional cell culture market.

As 3-dimensional cultures have the capacity to closely mimic a typical morphology and microarchitecture of organs, these are continuously developed for the studies that require in vivo model systems to analyze the effect of a foreign drug over body tissues and organs. This, coupled with the availability of various choices in terms of material and structure of the scaffold for different in vitro applications, is anticipated to support revenue generation for scaffolds.

Recent researches have explored the use of a diverse range of scaffolds including graphene scaffolds, nanofibers, freeze-casting, natural marine collagen, and others. In addition, the application of lab-on-a-chip techniques in several assay types-proliferation, viability, stimulation, transport, patch clamping, high content screening, and metabolic activity-leads to a rise in demand for projects with advanced and efficient solutions.

Access Research Report of 3D Cell Culture Market @ https://www.grandviewresearch.com/industry-analysis/3d-cell-culture-market

3D Cell Culture Market Report Highlights

• The scaffold-based technology segment is anticipated to register a lucrative year-on-year growth owing to rising demand for 3D model-based research coupled with an increased incidence of chronic diseases
• Moreover, the introduction of novel tools and techniques is anticipated to boost revenue generation in the scaffold-based technology segment
• Furthermore, companies, such as Tecan and Sigma-Aldrich, offer scaffold-based 3D solutions; which are readily adopted by the end users
• Cancer was the largest application segment of the market in 2020. This is because 3D cultures efficiently replicate the associated influences and complexity of in vivo tumor microenvironment including the impact of extracellular matrix and cell-to-cell contact
• Cells in 3-dimensional cultures help in the analysis of behavior and properties of the tumor, protein distribution, gene expression, and monitor response to anticancer therapies
• Potential scientific and clinical impacts of the 3D-cultivation approach for embryonic, adult, and cancer stem cells are estimated to boost the growth of the stem cell research segment
• Biotechnology and pharmaceutical organizations accounted for the largest share in 2020 owing to a rise in the adoption of 3D cell culture techniques in tissue engineering and drug discovery
• Combination of 3D cell culture techniques with Human-induced Pluripotent Stem Cells (HiPSCs) has been successfully used for the development and discovery of drugs for liver diseases
• North America led the market in 2020 owing to extensive usage of 3D cell culture models for medical research purposes
• In April 2020, a team of researchers from the University of Pittsburgh used Multicellular Tumor Spheroids (MCTSs) to assess drug responses in drug screening studies for oncology
• Asia Pacific is expected to register the fastest CAGR from 2021 to 2028 due to rising investments by North American and European companies in APAC regional market
• The key market players focus on geographical expansions, partnerships, collaborations, acquisitions, and novel product launches to reinforce their market presence
• For instance, in December 2020, Curiteva, Inc. acquired FossiLabs, LLC. The latter has developed a process to fabricate scaffolding structures that promote osseointegration

List of Key Players of 3D Cell Culture Market

• Merck KGaA
• Thermo Fisher Scientific, Inc.
• PromoCell GmbH
• Greiner Bio One International GmbH
• Corning, Inc.
• 3D Biomatrix
• Lonza
• Avantor Performance Materials, LLC
• Tecan Trading AG
• 3D Biotek LLC
• Global Cell Solutions, Inc.
• InSphero

Access Press Release of 3D Cell Culture Market @ https://www.grandviewresearch.com/press-release/global-3d-cell-culture-market

Medical Foods Market Size Worth $ 30.34 Billion By 2028: Grand View Research Inc.

San Francisco, 28 Jan 2021: The Report Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration, By Product (Pills, Powder), By Application, By Sales Channel, By Region, And Segment Forecasts, 2021 – 2028

The global medical foods market size is anticipated to reach USD 30.34 billion by 2028 according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% over the forecast period. Factors such as the growing prevalence of chronic conditions along with the increasing geriatric population adopting medical foods are positively impacting the growth. Rising awareness regarding clinical nutrition among healthcare professionals and patients is projected to further bolster the growth over the forecast period.

Based on the route of administration, oral administration dominated the market in 2020. Factors contributing to the high share include high commercial viability of orally administered products and high preference for orally administered medical foods owing to ease in consumption. Oral supplements are available in various forms such as powders, pills, puddings, and pre-thickened products, thereby propelling the overall growth.

In 2020, based on product type, the others segment accounted for the highest revenue share. The others’ segment comprises of liquid, semi-liquid, and semi-solid products. This growth is attributed to increasing application areas of medical foods, high commercial availability, and easy administration of these products. Owing to ease of consumption, liquid formulations are preferred by geriatric as well as pediatric populations, thereby increasing its overall revenue share.

Based on application, diabetic neuropathy dominated the market share in 2020. Rising diabetes prevalence and an increase in the number of patients that are at risk of developing some level of neuropathy are some of the factors boosting the overall growth. For instance, according to Healthline, around 60% to 70% of people suffering from diabetes have some or other form of neuropathy. The risk of suffering from neuropathy increases with an aging, unhealthy lifestyle, and change in diet which leads to an increased focus on nutritional management, thereby fueling the growth.

In 2020, based on sales channels, institutional sales accounted for the highest revenue share. This share is attributable to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers. There is an increase in demand for such products in inpatient facilities. Hence, rising demand and consumption of these products under medical supervision are some of the factors contributing to the growth of the segment.

North America dominated the market with a revenue share of 29.9% in 2020 owing to the presence of key market players and high revenue generated by these players in this region. Strategic initiatives by players, increasing prevalence of chronic conditions, and rising adoption of medical foods by healthcare professionals and patients are other factors supporting the regional market growth.

Access Research Report of Medical Foods Market @ https://www.grandviewresearch.com/industry-analysis/medical-foods-market

Medical Foods Market Report Highlights

• The oral segment accounted for the highest revenue share in 2020, owing to the high commercial viability of orally administered products and high preference for orally administered medical foods
• The others’ segment dominated the market in 2020, owing to increasing application areas, high commercial availability, and easy administration of the products
• Diabetic Neuropathy dominated the market in 2020, owing to increasing diabetes prevalence and the rising number of patients that are at risk of developing some level of neuropathy
• Institutional sales accounted for the highest revenue share in 2020, owing to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers
• North America dominated the market with a revenue share of 29.9% in 2020, owing to the presence of key market players and high revenue generated by these players in this region

List of Key Players of Medical Foods Market

• Danone
• Nestle Nutrition
• Abbott Nutrition
• Targeted Medical Pharma, Inc.
• Primus Pharmaceuticals, Inc.
• Mead Johnson & Company, LLC.
• Medtrition, Inc.
• Fresenius Kabi AG

Access Press Release of Medical Foods Market @ https://www.grandviewresearch.com/press-release/global-medical-foods-market

In Vitro Diagnostics Market Size Is Projected To Reach USD 113.9 Billion By 2027: Grand View Research Inc.

San Francisco, 28 Jan 2021: The Report In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics), By End-use, By Region, And Segment Forecasts, 2021 – 2027

The global in vitro diagnostics market size is expected to reach USD 113.9 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.5% from 2021 to 2027. The growth is driven by the growing geriatric population and technological advancements in diagnostics that are supporting its adoption.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high impact rendering drivers of this market. For instance, in June 2017, Agena Bioscience launched the MassARRAY system integrated with CHIP Prep Module in Europe. The system was marketed as a CE-IVD product under Directive 98/79/EC. Moreover, Real-Time Polymerase Chain Reaction (qPCR) is one of the fastest-growing application segments of the in vitro diagnostics (IVD) market.

The IVD market is highly competitive in nature. Consequently, manufacturers are required to improvise products in terms of specificity, accuracy, precision, speed, and other parameters, in order to gain an advantage over previously marketed products.

A steady rise in consumer awareness about diagnosing infectious diseases and increasing disease prevalence, especially in developing and under-developed countries, are driving the market penetration of the products. For instance, in February 2019, Abbott received CE Mark for DETERMINE HBSAG 2 test for detection and diagnosis of hepatitis B surface antigen.

Organizations promote funding to support R&D and product development exercises pertaining to clinical diagnostics. For instance, Vela Diagnostics received USD 225,000 as Biomedical Advanced Research and Development Authority (BARDA) fund to develop COVID-19 tests. Moreover, the introduction of the American Health Care Act of 2017 is expected to improve the healthcare of the U.S. Rising government initiatives pertaining to the importance of IVD will fuel market growth.

The presence of effective technologies such as molecular diagnostics is expected to reduce the threat of substitutes. Moreover, their contribution in the field of genetic testing is of paramount importance and, therefore, experience a low threat of substitutes. However, high prices of these tests are expected to encourage patients to shift to external substitutes.

Major players in the market are Roche Diagnostics; Becton Dickinson; Abbott Laboratories; Siemens; and bioMerieux, which are well-established. Therefore, local companies and new organizations have little scope to enter the market and ensure sustainability. However, companies such as Danaher Corporation and Hologic have successfully excelled in the market through mergers and acquisitions. The seed capital required is high.

Access Research Report of In Vitro Diagnostics Market @ https://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-market

In Vitro Diagnostics Market Report Highlights

• Molecular diagnostics is expected to witness the fastest growth over the forecast period
• High use of reagents in IVD testing, high demand for over-the-counter diagnostic tests, and increase in adoption of these tests in nonmedical facilities, such as home, are some of the factors that are driving the growth, providing it a clinical advantage over other IVD tests
• Reagents held the largest market share in 2020 owing to the increasing demand for genetic testing and availability of technologically advanced cancer diagnostic tests in countries with unmet clinical needs, such as India and Middle East & Africa
• The growing availability of CE-IVD certified kits globally to diagnose and screen patients during epidemic situations is expected to boost the growth of reagents and instruments segments
• Key players are updating their range of testing options for qPCR instruments by undertaking R&D initiatives for the development of kits that target emerging diseases, or by entering into agreements with other kit manufacturing companies

List of Key Players of In Vitro Diagnostics Market

• Abbott
• Danaher
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson and Company
• Siemens Healthineers AG
• QIAGEN
• Quidel Corporation
• Hoffmann-La Roche AG
• Sysmex Corporation
• Charles River Laboratories International, Inc.
• Quest Diagnostics
• Agilent Technologies

Access Press Release of In Vitro Diagnostics Market @ https://www.grandviewresearch.com/press-release/global-in-vitro-diagnostics-market

Craniomaxillofacial Devices Market Projected To Exhibit Robust CAGR of 9.0%For The Forecast Period From 2021 To 2028: Grand View Research Inc.

San Francisco, 28 Jan 2021: The Report Craniomaxillofacial Devices Market Size, Share & Trends Analysis Report By Material (Metal, Ceramics), By Product (CMF Plate & Screw Fixation, Bone Graft Substitute), By Application, And Segment Forecasts, 2021 – 2028

The global craniomaxillofacial devices market size is expected to reach USD 3.2 billion by 2028 registering a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. Craniofacial surgery treats conditions that affect the head, skull, face, and neck. The rise in the number of facial and head injuries caused due to road accidents and increasing cases of sports-related injuries are expected to boost demand for craniomaxillofacial (CMF) devices.

Growing preferencefor minimally invasive surgeries is also one of the key factors expected to support market growth. Organizations, such as the American Society of Craniofacial Surgery (ASCFS) and the International Society of Craniofacial Surgery (ISCFS), are conducting a research program in a probe to increase awareness of CMF surgeries, boosting consumer awareness about the craniomaxillofacial devices. This is also projected to help boost the overall market growth.

Neck injuries are one of the most common types of injuries in vehicle accidents. Over 800, 000 cases of vehicle crashes involving neck injuries are reported per year in the U.S. Moreover, sports injuries, car accidents, and falls were some of the leading causes of head injuries in the country. Hence, the U.S. is expected to be a potential market for CMF device manufacturers. The global pandemic has led to the cancellation and rescheduling of surgical procedures, which will hamper the market growth to some extent.

Access Research Report of Craniomaxillofacial Devices Market @ https://www.grandviewresearch.com/industry-analysis/craniomaxillofacial-devices-market

Craniomaxillofacial Devices Market Report Highlights

• In 2020, the CMF plate and screw fixation segment led the global market due to the rise in the number of surgeries requiring bone stabilization
• The bioabsorbable material segment is estimated to register the fastest CAGR during the forecasted period due to technological advancements
• Neurosurgery & ENT is expected to be the fastest-growing application segment from 2021 to 2028 due to an increase in the volume of surgical procedures pertaining to trauma and the adoption of deep brain stimulation procedures
• Latin American region is projected to be the fastest-growing regional market during the forecast period on account of rising cases of accidents in Brazil and Mexico

List of Key Players of Craniomaxillofacial Devices Market

• DePuy Synthes (J&J)
• Stryker Corp.
• Medtronic plc
• Zimmer Biomet

Access Press Release of Craniomaxillofacial Devices Market @ https://www.grandviewresearch.com/press-release/global-cmf-devices-market

Brain Health Supplements Market Size Is Poised To Reach USD 13.38 Billion By 2028: Grand View Research Inc.

San Francisco, 28 Jan 2021: The Report Brain Health Supplements Market Size, Share & Trends Analysis Report By Product (Natural Molecules, Herbal Extract), By Application (Memory Enhancement, Depression & Mood), By Region, And Segment Forecasts, 2021 – 2028

The global brain health supplements market size is expected to reach USD 13.38 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2021 to 2028. The rising awareness among consumers regarding mental health is fueling the adoption of supplements over the world. The increasing brain health issues, such as depression and dementia, boost the demand for the products. Depression, stress, and anxiety are common mental illnesses among adolescents and millennials. Furthermore, the COVID-19 pandemic has heightened the occurrence of these mental illnesses over the world and boosted the demand for brain health supplements.

Natural molecules accounted for the largest market share in 2020. The expansion of this segment is attributed to the easy availability and cost-effectiveness of the products. The natural ingredients in these products, including omega-3 fatty acids, Huperzine-A, and Acetyl-L-carnitine, help in improving the focus and easing stress, anxiety, and depression. Herbal extract products are expected to expand at the fastest CAGR of 9.2% from 2021 to 2028.

The supplements for memory enhancement dominated the market in 2020, with more than 25.0% revenue share due to the increased number of Alzheimer’s patients worldwide. According to the Alzheimer’s Association, as of 2020, around 5.8 million people in the U.S. had Alzheimer’s. The growing number of the aging population has been driving the demand for memory enhancement supplements as memory loss is a widespread illness among the older population.

The industry is competitive with a large number of large and medium-sized firms across the globe. New product launches are expected to remain a key trend in the industry. In April 2019, Reckitt Benckiser Group plc. introduced Neuriva supplement, with complimentary digital support and training program. The product is designed to improve cognitive functions, including focus, memory, and consumers’ concentration.

Access Research Report of Brain Health Supplements Market @ https://www.grandviewresearch.com/industry-analysis/brain-health-supplements-market

Brain Health Supplements Market Report Highlights

• By product, the herbal extract segment is expected to register the fastest CAGR of 9.2% from 2021 to 2028 owing to the increasing preference for herbal products among the consumers
• North America dominated the market with over 35.0% revenue share in 2020. Increased concerns about brain health, along with the expanded prevalence of Alzheimer’s among elderly people, have been boosting the market growth in the region
• The memory enhancement application segment held the largest share of more than 25.0% in 2020

List of Key Players of Brain Health Supplements Market

• Teva Pharmaceutical Industries Ltd.
• HVMN Inc.
• Purelife Bioscience Co., Ltd.
• Peak Nootropics
• AlternaScript
• Liquid Health, Inc.
• Natural Factors Nutritional Products Ltd.
• Reckitt Benckiser Group plc.
• Onnit Labs, Inc.
• Quincy Bioscience

 Access Press Release of Brain Health Supplements Market @ https://www.grandviewresearch.com/press-release/global-brain-health-supplements-market

Electric Motor Sales Market Size Is Estimated To Reach USD 232.5 Billion By 2028: Grand View Research Inc.

San Francisco, 27 Jan 2021: The Report Electric Motor Sales Market Size, Share & Trends Analysis Report By Application, By Power Output (Integral HP Output, Fractional HP Output), By Motor Type (Hermetic, AC, DC), By Region, And Segment Forecasts, 2021 – 2028

The global electric motor sales market size is expected to reach USD 232.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. Rapid technological advancements have been playing an imperative role in the growth of the market. Further, improved insulation and operational efficiency have significantly improved the electro-mechanical machines in terms of safety and functionalities, leading to increased demand across multiple industries. Electric motors are used in multiple applications across industry verticals such as home appliances, industrial machinery, and vehicles. The market is expected to witness high growth from Heating, Ventilation, and Cooling (HVAC) applications as they are an inseparable component of HVAC equipment.

Rising fuel prices across the globe are impelling people to shift to non-conventional fuel alternatives. As a result, electric vehicles are manufactured with a view of reducing operational costs and carbon footprint. The upsurge in the production of electric vehicles is expected to positively impact the demand for electric motors as they are used in various applications ranging from performance components to comfort components of the vehicle.

The industry is characterized by regulatory policies and government initiatives that promote energy efficiency in machines and equipment. High-efficiency and output, low power consumption, increased operational life, and low maintenance costs are essential requirements for the electro-mechanical machines. Notably, technological innovations have introduced improved design, components, and motor specifications resulting in fulfillment of end-user requirements. Innovations and evolving policy frameworks are crucial for industry development and will play a key role in fueling the demand for the products over the forecast period.

Asia Pacific region held the largest revenue share in the electric motor market in 2020 and is projected to witness the fastest CAGR of 7.8% from 2021 to 2028. The growth can be attributed to increasing industrialization investments in countries such as China, India, South Korea, and Australia. Further, the scope for market growth in the region is expected to increase significantly over the coming years, owing to the evolving agriculture sector through efficient irrigation practices and technology transfer.

Access Research Report of Electric Motor Sales Market @ https://www.grandviewresearch.com/industry-analysis/electric-motor-market

Electric Motor Sales Market Report Highlights

• Increased adoption of the electro-mechanical machines in vehicles, backed by technological advancements resulting in performance enhancement, is expected to positively impact market’s growth
• The AC motor type held the largest share in 2020. It is estimated to generate over USD 166 billion by 2028 due to the extensive use of AC motors in various applications ranging from irrigation pumps to modern-day robotics
• The fractional horsepower (FHP) output segment represented over 87% of the overall market value in 2020. Fractional horsepower motors are used widely in all household appliances ranging from vacuum cleaners to coffee machines to refrigerators
• The motor vehicles segment is the most prominent application segment, commanding more than 40.0% of the overall market value in 2020. The electro-mechanical machines are also extensively used in heavy industrial equipment as well as agricultural machinery
• Asia Pacific will lead the market through 2028, exhibiting a CAGR of 7.8% from 2021 to 2028. The growth of the regional market can be attributed to increasing direct investments in developing nations such as India and China

List of Key Players of the Electric Motor Sales Market

• Baldor Electric Company, Inc.
• Ametek Inc.
• Franklin Electric Co., Inc.
• Asmo Co., Ltd.

Access Press Release of Electric Motor Sales Market @ https://www.grandviewresearch.com/press-release/global-electric-motor-market